Historical Archives

Media Contacts:
Kristy Marks
kristy.marks@bausch.com
(908) 927-0683

Don Murphy
don.murphy@zenogroup.com
(212) 299-8970

JOSEPH GORDON NAMED U.S. PRESIDENT OF BAUSCH + LOMB

Veteran Executive Selected to Oversee All Four U.S. Bausch + Lomb Business Units

BRIDGEWATER, N.J., Aug. 20, 2018 – Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), today announced that Joseph Gordon has been named U.S. president, Bausch + Lomb. In this role, Gordon will oversee the fully integrated U.S. eye care business, inclusive of all four business units - Vision Care, Consumer Health, Surgical and Pharmaceuticals - reporting directly to chairman and CEO of Bausch Health, Joseph C. Papa.

“Bausch + Lomb is an integral part of our business and the largest of the four Bausch Health segments, representing more than 50% of our revenues,” said Papa. “The expansion of Joe’s role reflects the company’s focus on driving growth through our continued transformation – from recently changing our name to Bausch Health and realigning our operating and reportable segments - and the opportunity to build upon Bausch + Lomb’s leadership in eye health as we continue to invest in this important core business. As we look to the next phase of growth for Bausch Health, I am confident that Joe’s strong management background and proven track record of success will further accelerate the growth of Bausch + Lomb, ultimately helping to improve the vision of patients.”

Gordon was most recently the president of Bausch + Lomb’s Consumer Health and Vision Care businesses. During his seven-year tenure at the company, he has led the Bausch + Lomb Consumer Healthcare business to achieve consecutive industry-leading growth for the past six years, bolstered in part by key over-the-counter (OTC) brands such as new LUMIFY™ redness reliever eye drops, the No. 1 doctor recommended redness reliever and Biotrue® multi-purpose solution, the No. 1 multi-purpose solution in households. Both key contact lens brands in Vision Care, Bausch + Lomb ULTRA® and Biotrue® ONEday, are also the fasting growing in their respective segments.

About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.

###

MTB.0425.USA.18